Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form sticky plaques in the brains of Alzheimer’s disease patients. The drug had been particularly effective in...
  • @blackfire
    3•2 years ago

    Damn thats insane. I remember hearing about the study and it being a big step in medical field. How did nobody peer reviewing it look at the images and compare them. Shows a broken system